Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Clinical trial NCT07555938 · RECRUITING
Trial details
- NCT number
- NCT07555938
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-23
- Primary completion
- 2028-10-31
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.